Concurrent development of "Burkitt-like" lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin

被引:4
作者
Kobayashi, Hiroshi [1 ]
Ichikawa, Motoshi [1 ]
Hangaishi, Akira [1 ]
Imai, Yoichi [1 ]
Kurokawa, Mineo [1 ]
机构
[1] Univ Tokyo, Dept Hematol & Oncol, Grad Sch Med, Tokyo, Japan
关键词
Burkitt-like lymphoma; IgH/BCL-2; c-MYC; Transformation; Follicular lymphoma; FOLLICULAR LYMPHOMA; C-MYC; TRANSFORMATION; EXPRESSION; GENE; REARRANGEMENTS; TRANSLOCATION; BREAKPOINTS; FEATURES;
D O I
10.1007/s12185-010-0741-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt lymphoma (BL) is a new entity in WHO classification 2008, and includes Burkitt-like transformation of follicular lymphoma (FL). However, the pathological significance of BCL-2/IgH translocation, which is characteristic in FL, in newly diagnosed cases of this disease is not well understood. We report a patient who developed B cell lymphoma with BL-like morphology on the shoulder, whose bone marrow was involved with FL-like cells. BL-like tumor cells harbored amplified c-MYC genes with BCL-2/IgH translocation, but FL-like cells solely had BCL-2/IgH translocation. The sequence analysis of the IgH gene revealed both of cells originated from the same clone, showing that the aggressive BL-like tumor originated from the FL-like clones simultaneously found in the bone marrow. This case suggests that the IgH/BCL-2 translocation found in newly diagnosed Burkitt-like lymphoma indicates a history of FL-like indolent lymphoma, even if such history is not documented.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 21 条
[1]   MATURATION OF THE IMMUNE-RESPONSE IN GERMINAL-CENTERS [J].
BEREK, C ;
BERGER, A ;
APEL, M .
CELL, 1991, 67 (06) :1121-1129
[2]   Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas [J].
Bertrand, P. ;
Bastard, C. ;
Maingonnat, C. ;
Jardin, F. ;
Maisonneuve, C. ;
Courel, M-N ;
Ruminy, P. ;
Picquenot, J-M ;
Tilly, H. .
LEUKEMIA, 2007, 21 (03) :515-523
[3]   The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features [J].
Braziel, RM ;
Arber, DA ;
Slovak, ML ;
Gulley, ML ;
Spier, C ;
Kjeldsberg, C ;
Unger, J ;
Miller, TP ;
Tubbs, R ;
Leith, C ;
Fisher, RI ;
Grogan, TM .
BLOOD, 2001, 97 (12) :3713-3720
[4]   ACTIVATION OF THE C-MYC ONCOGENE IN A PRECURSOR-B-CELL BLAST CRISIS OF FOLLICULAR LYMPHOMA, PRESENTING AS COMPOSITE LYMPHOMA [J].
DEJONG, D ;
VOETDIJK, BMH ;
BEVERSTOCK, GC ;
VANOMMEN, GJB ;
WILLEMZE, R ;
KLUIN, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (21) :1373-1378
[5]  
Haralambieva E, 2005, AM J SURG PATHOL, V29, P1086
[6]   INTRACLONAL GENERATION OF ANTIBODY MUTANTS IN GERMINAL-CENTERS [J].
JACOB, J ;
KELSOE, G ;
RAJEWSKY, K ;
WEISS, U .
NATURE, 1991, 354 (6352) :389-392
[7]   Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival [J].
Johnson, Nathalie A. ;
Savage, Kerry J. ;
Ludkovski, Olga ;
Ben-Neriah, Susana ;
Woods, Ryan ;
Steidl, Christian ;
Dyer, Martin J. S. ;
Siebert, Reiner ;
Kuruvilla, John ;
Klasa, Richard ;
Connors, Joseph M. ;
Gascoyne, Randy D. ;
Horsman, Douglas E. .
BLOOD, 2009, 114 (11) :2273-2279
[8]   VARIABLE BREAKPOINTS IN BURKITT-LYMPHOMA CELLS WITH CHROMOSOMAL T(8-14) TRANSLOCATION SEPARATE C-MYC AND THE IGH LOCUS UP TO SEVERAL 100 KB [J].
JOOS, S ;
FALK, MH ;
LICHTER, P ;
HALUSKA, FG ;
HENGLEIN, B ;
LENOIR, GM ;
BORNKAMM, GW .
HUMAN MOLECULAR GENETICS, 1992, 1 (08) :625-632
[9]  
Kluin P., 2008, B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma, V4th, P265
[10]   Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: Results of cancer and leukemia group B study 9251 [J].
Lee, EJ ;
Petroni, GR ;
Schiffer, CA ;
Freter, CE ;
Johnson, JL ;
Barcos, M ;
Frizzera, G ;
Bloomfield, CD ;
Peterson, BA .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) :4014-4022